Market - Page 12 of 314 - Express Pharma

Climate change to drive growth in multiple sclerosis market: GlobalData

Orchid Pharma receives DCGI approval for its antibiotic drug combination of Cefepime and Enmetazobactam (NCE)

Biosimilar market poised for significant growth in the coming years: GlobalData

Jubilant Pharma completes stake sale in Sofie Biosciences

Torrent pharma enters into non – exclusive patent licensing agreement with Takeda Pharma

Heightened consciousness towards sustainable practices driving Indian wooden pallet sector

Biopharma industry’s growth optimism surges but lags behind 2022 levels: GlobalData

PROTACs oncology market to hit $3.7 billion by 2030 despite lack of approved therapies: GlobalData

Pharma funding sees volatile shifts in May 2024

Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)